Immunocore Open menu Payments and Disclosures Relationships with Patient Organisations At Immunocore, we value collaboration and partnerships. Our commitment to working with patient organisations for the benefit of patients, is in accordance with the requirements of Clause 27 of the ABPI Code of Practice for the Pharmaceutical Industry. Immunocore upholds the highest standards of integrity in the way that we conduct business and we fully support the industry movement toward increased transparency of financial relationships. Disclosure of our financial support to patient organisations is one of the activities that we undertake to improve transparency concerning Company dealings with third parties. Immunocore declares that the Company has made its best efforts to make a comprehensive disclosure of concerned activities for 2019 and from hereon in. Payments and disclosures 2019 Immunocore About us Our science Our therapy areas For patients Investors/Media Careers Contact us Privacy and Social Media Guidelines Cookies Payments and Disclosures Clinical trials Gender Pay Report ©2021 Immunocore, Ltd. All rights reserved. ImmTAC, ImmTAV, ImmTAB, ImmTAAI and ImmTAX are all registered trademarks of Immunocore, Ltd To offer you a better experience, this site uses cookies, including those of third parties. To find out more and manage your preferences, consult the Cookie notice I Accept